Cortisol secretion and Alzheimer's disease progression

A preliminary report

Myron F. Weiner, Stephen Vobach, Doris Svetlik, Richard C. Risser

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

We report preliminary findings in a study of the relationship of plasma cortisol concentration (CORT) to the clinical progression of Alzheimer's disease (AD), testing the hypotheses that CORT predicts AD progression and that CORT increases as the disease advances. In 12 subjects with NINCDS/ADRDA probable AD, we performed cognitive testing and plasma cortisol determinations at baseline and again in 12 months. A modified Alzheimer's Disease Assessment Scale-Cognitive (ADAS-COG) measured disease progression. Plasma cortisol concentration CORT was determined at 12 am and 1 pm, and an Afternoon Cortisol Test (ACT) was used to estimate average 24-hr CORT. Baseline 12 am CORT correlated with the change in ADAS-COG from start of study to 12 months. No cortisol measure increased over the study period; estimated average 24-hr CORT and 12 am CORT remained constant, whereas while 1 pm CORT declined. There was no relationship between age or duration of illness and any of the cortisol measures at baseline.

Original languageEnglish (US)
Pages (from-to)158-161
Number of pages4
JournalBiological Psychiatry
Volume34
Issue number3
DOIs
StatePublished - Aug 1 1993

Fingerprint

Disease Progression
Hydrocortisone
Alzheimer Disease

Keywords

  • Alzheimer's disease
  • cortisol

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Cortisol secretion and Alzheimer's disease progression : A preliminary report. / Weiner, Myron F.; Vobach, Stephen; Svetlik, Doris; Risser, Richard C.

In: Biological Psychiatry, Vol. 34, No. 3, 01.08.1993, p. 158-161.

Research output: Contribution to journalArticle

Weiner, Myron F. ; Vobach, Stephen ; Svetlik, Doris ; Risser, Richard C. / Cortisol secretion and Alzheimer's disease progression : A preliminary report. In: Biological Psychiatry. 1993 ; Vol. 34, No. 3. pp. 158-161.
@article{949573cda02c48e3ad40f8d78a45f5a6,
title = "Cortisol secretion and Alzheimer's disease progression: A preliminary report",
abstract = "We report preliminary findings in a study of the relationship of plasma cortisol concentration (CORT) to the clinical progression of Alzheimer's disease (AD), testing the hypotheses that CORT predicts AD progression and that CORT increases as the disease advances. In 12 subjects with NINCDS/ADRDA probable AD, we performed cognitive testing and plasma cortisol determinations at baseline and again in 12 months. A modified Alzheimer's Disease Assessment Scale-Cognitive (ADAS-COG) measured disease progression. Plasma cortisol concentration CORT was determined at 12 am and 1 pm, and an Afternoon Cortisol Test (ACT) was used to estimate average 24-hr CORT. Baseline 12 am CORT correlated with the change in ADAS-COG from start of study to 12 months. No cortisol measure increased over the study period; estimated average 24-hr CORT and 12 am CORT remained constant, whereas while 1 pm CORT declined. There was no relationship between age or duration of illness and any of the cortisol measures at baseline.",
keywords = "Alzheimer's disease, cortisol",
author = "Weiner, {Myron F.} and Stephen Vobach and Doris Svetlik and Risser, {Richard C.}",
year = "1993",
month = "8",
day = "1",
doi = "10.1016/0006-3223(93)90386-R",
language = "English (US)",
volume = "34",
pages = "158--161",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Cortisol secretion and Alzheimer's disease progression

T2 - A preliminary report

AU - Weiner, Myron F.

AU - Vobach, Stephen

AU - Svetlik, Doris

AU - Risser, Richard C.

PY - 1993/8/1

Y1 - 1993/8/1

N2 - We report preliminary findings in a study of the relationship of plasma cortisol concentration (CORT) to the clinical progression of Alzheimer's disease (AD), testing the hypotheses that CORT predicts AD progression and that CORT increases as the disease advances. In 12 subjects with NINCDS/ADRDA probable AD, we performed cognitive testing and plasma cortisol determinations at baseline and again in 12 months. A modified Alzheimer's Disease Assessment Scale-Cognitive (ADAS-COG) measured disease progression. Plasma cortisol concentration CORT was determined at 12 am and 1 pm, and an Afternoon Cortisol Test (ACT) was used to estimate average 24-hr CORT. Baseline 12 am CORT correlated with the change in ADAS-COG from start of study to 12 months. No cortisol measure increased over the study period; estimated average 24-hr CORT and 12 am CORT remained constant, whereas while 1 pm CORT declined. There was no relationship between age or duration of illness and any of the cortisol measures at baseline.

AB - We report preliminary findings in a study of the relationship of plasma cortisol concentration (CORT) to the clinical progression of Alzheimer's disease (AD), testing the hypotheses that CORT predicts AD progression and that CORT increases as the disease advances. In 12 subjects with NINCDS/ADRDA probable AD, we performed cognitive testing and plasma cortisol determinations at baseline and again in 12 months. A modified Alzheimer's Disease Assessment Scale-Cognitive (ADAS-COG) measured disease progression. Plasma cortisol concentration CORT was determined at 12 am and 1 pm, and an Afternoon Cortisol Test (ACT) was used to estimate average 24-hr CORT. Baseline 12 am CORT correlated with the change in ADAS-COG from start of study to 12 months. No cortisol measure increased over the study period; estimated average 24-hr CORT and 12 am CORT remained constant, whereas while 1 pm CORT declined. There was no relationship between age or duration of illness and any of the cortisol measures at baseline.

KW - Alzheimer's disease

KW - cortisol

UR - http://www.scopus.com/inward/record.url?scp=0027292443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027292443&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(93)90386-R

DO - 10.1016/0006-3223(93)90386-R

M3 - Article

VL - 34

SP - 158

EP - 161

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -